Friday, May 20, 2022

Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders

Scientists have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.

from Latest Science News -- ScienceDaily https://ift.tt/vbSfPCx
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

They fled the flames—now jaguars rule a wetland refuge

After devastating wildfires scorched the Brazilian Pantanal, an unexpected phenomenon unfolded—more jaguars began arriving at a remote wetla...